RSS-Feed abonnieren
Bitte kopieren Sie die angezeigte URL und fügen sie dann in Ihren RSS-Reader ein.
https://www.thieme-connect.de/rss/thieme/de/10.1055-s-00000077.xml
PDF herunterladen
Semin Thromb Hemost 2023; 49(07): 661-669
DOI: 10.1055/s-0043-1772572
DOI: 10.1055/s-0043-1772572
Editorial
New Seminars in Thrombosis and Hemostasis 2022 Impact Factor, Most Highly Cited Papers, and Other Journal Metrics
Authors
This editorial continues our current approach to announce our newest Journal Impact Factor (IF) and other journal metrics upon the release of the latest IF.[1] [2]
Publikationsverlauf
Artikel online veröffentlicht:
23. August 2023
© 2023. Thieme. All rights reserved.
Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA
-
References
- 1
Favaloro EJ.
New STH (2020) impact factor, most highly cited papers, and other journal metrics.
Semin Thromb Hemost 2021; 47 (07) 745-753
Reference Ris Wihthout Link
- 2
Favaloro EJ.
New Seminars in Thrombosis and Hemostasis (STH) 2021 impact factor, most highly cited
papers, and other journal metrics. Semin Thromb Hemost 2022; 48 (06) 634-642
Reference Ris Wihthout Link
- 3 COVID-19 Dashboard by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University. . (JHU). Accessed 30th June, 2023 at: https://www.arcgis.com/apps/dashboards/bda7594740fd40299423467b48e9ecf6
- 4 National Library of Medicine/National Center for Biotechnology Information/PubMed. . com. Accessed 30th June, 2023 at: https://pubmed.ncbi.nlm.nih.gov/?term=covid-19
- 5
Favaloro EJ,
Lippi G.
Maintaining hemostasis and preventing thrombosis in coronavirus disease 2019 (COVID-19)—Part
I. Semin Thromb Hemost 2020; 46 (07) 757-762
Reference Ris Wihthout Link
- 6
Favaloro EJ,
Lippi G.
Maintaining hemostasis and preventing thrombosis in coronavirus disease 2019 (COVID-19):
Part II. Semin Thromb Hemost 2021; 47 (04) 333-337
Reference Ris Wihthout Link
- 7
Favaloro EJ,
Lippi G.
Maintaining hemostasis and preventing thrombosis in coronavirus disease 2019 (COVID-19)—Part
III. Semin Thromb Hemost 2022; 48 (01) 3-7
Reference Ris Wihthout Link
- 8
Favaloro EJ,
Pasalic L,
Lippi G.
Maintaining Hemostasis and Preventing Thrombosis in Coronavirus Disease 2019 (COVID-19)-Part
IV. Semin Thromb Hemost 2023; 49 (01) 3-8
Reference Ris Wihthout Link
- 9
Favaloro EJ.
2021 Eberhard F. Mammen Award Announcements: Part I—most popular articles. Semin Thromb
Hemost 2021; 47 (05) 467-476
Reference Ris Wihthout Link
- 10
Favaloro EJ.
2022 Eberhard F. Mammen Award Announcements: Part I—most popular articles. Semin Thromb
Hemost 2022; 48 (05) 502-513
Reference Ris Wihthout Link
- 11
Favaloro EJ.
2023 Eberhard F. Mammen Award Announcements: Part I—Most Popular Articles. Semin Thromb
Hemost 2023; 49 (05) 417-426
Reference Ris Wihthout Link
- 12
Favaloro EJ.
The Journal Impact Factor: don't expect its demise any time soon. Clin Chem Lab Med
2009; 47 (11) 1319-1324
Reference Ris Wihthout Link
- 13
Favaloro EJ.
Measuring the quality of journals and journal articles: the impact factor tells but
a portion of the story. Semin Thromb Hemost 2008; 34 (01) 7-25
Reference Ris Wihthout Link
- 14 Di Minno A, Ambrosino P, Calcaterra I, Di Minno MND. COVID-19 and venous thromboembolism: a meta-analysis of literature studies. Semin Thromb Hemost 2020; 46 (07) 763-771
- 15
Favaloro EJ,
Henry BM,
Lippi G.
Increased VWF and decreased ADAMTS-13 in COVID-19: Creating a Milieu for (Micro)Thrombosis.
Semin Thromb Hemost 2021; 47 (04) 400-418
Reference Ris Wihthout Link
- 16 Iba T, Levi M, Levy JH. Sepsis-induced coagulopathy and disseminated intravascular coagulation. Semin Thromb Hemost 2020; 46 (01) 89-95
- 17 Parisi R, Costanzo S, Di Castelnuovo A, de Gaetano G, Donati MB, Iacoviello L. Different anticoagulant regimens, mortality, and bleeding in hospitalized patients with COVID-19: a systematic review and an updated meta-analysis. Semin Thromb Hemost 2021; 47 (04) 372-391
- 18 Engelen MM, Vandenbriele C, Balthazar T. et al. Venous thromboembolism in patients discharged after COVID-19 hospitalization. Semin Thromb Hemost 2021; 47 (04) 362-371
- 19 Levi M, Thachil J. Coronavirus disease 2019 coagulopathy: disseminated intravascular coagulation and thrombotic microangiopathy—either, neither, or both. Semin Thromb Hemost 2020; 46 (07) 781-784
- 20 Thachil J, Srivastava A. SARS-2 coronavirus-associated hemostatic lung abnormality in COVID-19: is it pulmonary thrombosis or pulmonary embolism?. Semin Thromb Hemost 2020; 46 (07) 777-780
- 21 Henry BM, Cheruiyot I, Benoit JL. et al. Circulating levels of tissue plasminogen activator and plasminogen activator inhibitor-1 are independent predictors of coronavirus disease 2019 severity: a prospective, observational study. Semin Thromb Hemost 2021; 47 (04) 451-455
- 22 Al-Samkari H, Kuter DJ. Immune thrombocytopenia in adults: modern approaches to diagnosis and treatment. Semin Thromb Hemost 2020; 46 (03) 275-288
- 23 Moore HB, Moore EE. Temporal changes in fibrinolysis following injury. Semin Thromb Hemost 2020; 46 (02) 189-198
- 24 Fernández-Capitán C, Barba R, Díaz-Pedroche MDC. et al. Presenting characteristics, treatment patterns, and outcomes among patients with venous thromboembolism during hospitalization for COVID-19. Semin Thromb Hemost 2021; 47 (04) 351-361
- 25 de Maat S, de Mast Q, Danser AHJ, van de Veerdonk FL, Maas C. Impaired breakdown of bradykinin and its metabolites as a possible cause for pulmonary edema in COVID-19 infection. Semin Thromb Hemost 2020; 46 (07) 835-837
- 26 Hartmann J, Walsh M, Grisoli A. et al. Diagnosis and treatment of trauma-induced coagulopathy by viscoelastography. Semin Thromb Hemost 2020; 46 (02) 134-146
- 27 Onorato D, Pucci M, Carpene G, Henry BM, Sanchis-Gomar F, Lippi G. Protective effects of statins administration in European and North American patients infected with COVID-19: a meta-analysis. Semin Thromb Hemost 2021; 47 (04) 392-399
- 28 Favaloro EJ, Lippi G. Recommendations for minimal laboratory testing panels in patients with COVID-19: potential for prognostic monitoring. Semin Thromb Hemost 2020; 46 (03) 379-382
- 29 Dorgalaleh A. Bleeding and bleeding risk in COVID-19. Semin Thromb Hemost 2020; 46 (07) 815-818
- 30 Christensen B, Favaloro EJ, Lippi G, Van Cott EM. Hematology laboratory abnormalities in patients with coronavirus disease 2019 (COVID-19). Semin Thromb Hemost 2020; 46 (07) 845-849
- 31 Lepedda AJ, Nieddu G, Piperigkou Z, Kyriakopoulou K, Karamanos N, Formato M. Circulating heparan sulfate proteoglycans as biomarkers in health and disease. Semin Thromb Hemost 2021; 47 (03) 295-307
- 32 Sokou R, Tsantes AG, Konstantinidi A. et al. Rotational thromboelastometry in neonates admitted to a neonatal intensive care unit: a large cross-sectional study. Semin Thromb Hemost 2021; 47 (07) 875-884
- 33 Lippi G, Henry BM, Favaloro EJ. Mean platelet volume predicts severe COVID-19 illness. Semin Thromb Hemost 2021; 47 (04) 456-459
- 34 Page MJ, Pretorius E. A champion of host defense: a generic large-scale cause for platelet dysfunction and depletion in infection. Semin Thromb Hemost 2020; 46 (03) 302-319
- 35 Black JA, Pierce VS, Kerby JD, Holcomb JB. The evolution of blood transfusion in the trauma patient: whole blood has come full circle. Semin Thromb Hemost 2020; 46 (02) 215-220
- 36 Schulman S. Coronavirus disease 2019, prothrombotic factors, and venous thromboembolism. Semin Thromb Hemost 2020; 46 (07) 772-776
- 37 Larsen JB, Pasalic L, Hvas AM. Platelets in coronavirus disease 2019. Semin Thromb Hemost 2020; 46 (07) 823-825
- 38 Thachil J, Lisman T. Pulmonary megakaryocytes in coronavirus disease 2019 (COVID-19): roles in thrombi and fibrosis. Semin Thromb Hemost 2020; 46 (07) 831-834
- 39 Meijenfeldt FAV, Jenne CN. Netting liver disease: neutrophil extracellular traps in the initiation and exacerbation of liver pathology. Semin Thromb Hemost 2020; 46 (06) 724-734
- 40 Khialani D, Rosendaal F, Vlieg AVH. Hormonal contraceptives and the risk of venous thrombosis. Semin Thromb Hemost 2020; 46 (08) 865-871
- 41 Stillson JE, Bunch CM, Gillespie L. et al. Thromboelastography-guided management of anticoagulated COVID-19 patients to prevent hemorrhage. Semin Thromb Hemost 2021; 47 (04) 442-446
- 42 Larsen JB, Hvas AM. Thrombin: a pivotal player in hemostasis and beyond. Semin Thromb Hemost 2021; 47 (07) 759-774
- 43 Dhami SPS, Patmore S, O'Sullivan JM. Advances in the management of cancer-associated thrombosis. Semin Thromb Hemost 2021; 47 (02) 139-149
- 44 Simion C, Campello E, Bensi E. et al. Use of glucocorticoids and risk of venous thromboembolism: a narrative review. Semin Thromb Hemost 2021; 47 (06) 654-661
- 45 Kwaan HC. Coronavirus disease 2019: the role of the fibrinolytic system from transmission to organ injury and sequelae. Semin Thromb Hemost 2020; 46 (07) 841-844
- 46 Lebreton A, Sinegre T, Lecompte T, Talon L, Abergel A, Lisman T. Thrombin generation and cirrhosis: state of the art and perspectives. Semin Thromb Hemost 2020; 46 (06) 693-703
- 47 Maegele M, Aversa J, Marsee MK. et al. Changes in coagulation following brain injury. Semin Thromb Hemost 2020; 46 (02) 155-166
- 48 Fang ZA, Navaei AH, Hensch L, Hui SR, Teruya J. Hemostatic management of extracorporeal circuits including cardiopulmonary bypass and extracorporeal membrane oxygenation. Semin Thromb Hemost 2020; 46 (01) 62-72
- 49 Abildgaard A, Madsen SA, Hvas AM. Dosage of anticoagulants in obesity: recommendations based on a systematic review. Semin Thromb Hemost 2020; 46 (08) 932-969
- 50 Favaloro EJ. 2020 Eberhard F. Mammen Award Announcements: Part II-Young Investigator Awards. Semin Thromb Hemost 2021; 47 (03) 229-237
- 51 Moore HB, Walsh M, Kwaan HC, Medcalf RL. The complexity of trauma-induced coagulopathy. Semin Thromb Hemost 2020; 46 (02) 114-115
- 52 Hunt BJ, Levy JH. Perioperative thrombosis and hemostasis. Semin Thromb Hemost 2020; 46 (01) 6-7
- 53 Hvas AM, Larsen JB, Pasalic L. Acquired platelet dysfunction-laboratory and clinical implications. Semin Thromb Hemost 2020; 46 (03) 235-237
- 54
Favaloro EJA.
2018 update on the editorial and publication policy of seminars in thrombosis and
hemostasis. Semin Thromb Hemost 2018; 44 (04) 307-311
Reference Ris Wihthout Link
- 55
Favaloro EJ.
A tribute to Eberhard F. Mammen, M.D. (1930-2008). Semin Thromb Hemost 2008; 34 (08)
703-707
Reference Ris Wihthout Link
- 56
Favaloro EJ.
A short history of Thrombosis and Hemostasis: part I (40th year celebratory issue).
Semin Thromb Hemost 2014; 40 (05) 521-525
Reference Ris Wihthout Link
- 57
Favaloro EJ.
A short history of thrombosis and hemostasis: part II (40th year celebratory issue).
Semin Thromb Hemost 2014; 40 (08) 826-830
Reference Ris Wihthout Link
- 58
Favaloro EJ.
Celebrating 50 Years of Seminars in Thrombosis and Hemostasis—part I. Semin Thromb
Hemost 2022; 48 (08) 871-874
Reference Ris Wihthout Link
- 59
Favaloro EJ.
Celebrating 50 Years of Seminars in Thrombosis and Hemostasis—part II. Semin Thromb
Hemost 2023; 49 (03) 212-216
Reference Ris Wihthout Link